# Tobacco Education and Lung Health Study (TEAL)

Source: https://onco.cc/trials/nct06290869/  
OnCo record `nct06290869` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in lung cancer, run by Georgetown University, now recruiting.

## Summary

Tobacco Education and Lung Health Study (TEAL) is a phase 3, randomised interventional study registered as NCT06290869 by Georgetown University, with a registry enrolment figure of 1188 participants, started 2024-02-22 and due to reach its primary completion in 2027-12-01. Interventions recorded: Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention; E-Referral to the Tobacco Quitline. Conditions listed: Smoking Cessation. Primary outcome: Biochemically verified smoking abstinence- MHS vs. QL-E arms; Biochemically verified smoking abstinence--continued MHS arm vs Stepped Care. Lung eligibility wording from the registry: "* prior lung cancer,". Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Also known as: TEAL
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06290869
- Phase: 3
- Setting: Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial (Tobacco Education and Lung Health Study)
- Sponsor: Georgetown University
- Enrolled: 1188

## Sources

- ClinicalTrials.gov NCT06290869: https://clinicaltrials.gov/study/NCT06290869

## Connected records

- cancers: [Lung cancer (all types)](https://onco.cc/cancers/lung-cancer/)
- technologies: [Low-dose CT lung screening](https://onco.cc/technologies/low-dose-ct-screening/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06290869.json